Cantor Fitzgerald reiterates Docebo stock rating on strong Q1 results By Investing.com

Docebo reported preliminary Q1 FY2026 revenue of $65.4 million to $65.6 million, about 3% above the $63.6 million consensus, with preliminary adjusted EBITDA of $10.8 million to $11.0 million versus $10.4 million expected. Annual recurring revenue rose 10.6% year over year to $248.9 million, and the company raised fiscal 2026 guidance after the strong quarter. Cantor Fitzgerald reiterated an Overweight rating and $28 target, while other analysts remained positive despite some target cuts; Docebo also unveiled its AI-powered AgentHub platform.

Analysis

The market is likely underappreciating that this is not just a clean execution print; it is a proof point that AI-driven productization can expand wallet share without needing a broad macro re-acceleration. The relevant second-order effect is that stronger EBITDA plus raised guidance gives Docebo room to defend pricing and accelerate product investment simultaneously, which can widen the gap versus slower-moving legacy LMS vendors that are still monetizing seat-based workflows. If the new AI module shortens implementation time and increases content generation efficiency, the operating leverage could compound over the next 2-3 quarters rather than showing up as a one-off beat.

The main catalyst path is not the Q1 number itself, but whether management can convert early AI enthusiasm into higher retention and expansion in the mid-market and enterprise cohorts. That matters because software names with sub-20x earnings and improving growth tend to rerate fastest when investors gain confidence that growth is durable rather than coupon-clipping from cost control. The FX drag also signals that reported growth may be understating underlying demand; if currencies stabilize, the next few prints could look mechanically better even before incremental sales acceleration.

Consensus may still be anchored to Docebo as a “good execution, modest growth” software name, missing that the AI launch can change the product narrative from LMS to workflow automation in corporate learning. The risk is that AI feature announcements often pull forward attention faster than revenue, so if pipeline conversion does not improve by the next two quarters, the multiple can compress back to a low-teens software valuation. The key inflection to watch is whether ARR ex-FX and ex-OEM continues to run above headline growth; if it does, this is more than a margin story and starts to look like a durable share-gain cycle.

Key Decisions for Investors

• Go long DCBO on any post-print consolidation over the next 1-2 weeks; target a re-rating toward higher-quality software peers if management sustains raised FY26 guidance and AI-related upsell commentary. Risk/reward is favorable as downside should be buffered by improving profitability and a low-teens earnings multiple.
• Buy DCBO call spreads 1-2 quarters out to express upside from guidance follow-through while limiting premium outlay; use strikes centered just above the current consensus target zone to monetize a rerating without paying for a full momentum extension.
• Pair long DCBO / short a slower-growth legacy enterprise software name with weaker AI monetization credibility over the next 3-6 months; the trade benefits if investors continue to reward efficient growth and penalize “AI theater” exposure.
• Use a stop if ARR growth decelerates again ex-FX/OEM in the next quarter; that would indicate the AI launch is not yet translating into repeatable demand and would likely cap the multiple expansion thesis.
• For investors already long software beta, overweight DCBO versus higher-multiple SaaS where execution is fine but growth is less differentiated; DCBO offers a cleaner mix of improving fundamentals and valuation support.